| Jasmin Chaudhary, MD | |
|
3025 Ryan Dr Se, Salem, OR 97301-5057 | |
| (503) 540-9999 | |
| (503) 540-3105 |
| Full Name | Jasmin Chaudhary |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 3025 Ryan Dr Se, Salem, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558596916 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | MD165759 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Salem Hospital | Salem, OR | Hospital |
| West Valley Hospital | Dallas, OR | Hospital |
| Willamette Valley Medical Center | Mcminnville, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Oncology Specialists Llp | 3971576240 | 38 |
News Archive
Nerve cells that regulate everything from heart muscle to salivary glands send out projections known as axons to their targets. By way of these axonal processes, neurons control target function and receive molecular signals from targets that return to the cell body to support cell survival. Now, Johns Hopkins researchers have revealed a molecular mechanism that allows a signal from the target to return to the cell body and fulfill its neuron-sustaining mission.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that results from studies highlighting pre-clinical advances with its proprietary BiTE antibody technology were presented at the American Association for Cancer Research Annual Meeting in Washington, DC.
Senetek PLC, a Life Sciences company engaged in the research, development and commercialization of technologies that target the science of healthy aging, today announced that the Senetek Board of Directors has implemented a new Corporate Communication policy to insure that the highest standards of corporate governance are met and that full compliance with all public company regulations is in place.
› Verified 5 days ago
| Entity Name | Oregon Oncology Specialists Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013953025 PECOS PAC ID: 3971576240 Enrollment ID: O20040816000322 |
News Archive
Nerve cells that regulate everything from heart muscle to salivary glands send out projections known as axons to their targets. By way of these axonal processes, neurons control target function and receive molecular signals from targets that return to the cell body to support cell survival. Now, Johns Hopkins researchers have revealed a molecular mechanism that allows a signal from the target to return to the cell body and fulfill its neuron-sustaining mission.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that results from studies highlighting pre-clinical advances with its proprietary BiTE antibody technology were presented at the American Association for Cancer Research Annual Meeting in Washington, DC.
Senetek PLC, a Life Sciences company engaged in the research, development and commercialization of technologies that target the science of healthy aging, today announced that the Senetek Board of Directors has implemented a new Corporate Communication policy to insure that the highest standards of corporate governance are met and that full compliance with all public company regulations is in place.
› Verified 5 days ago
| Entity Name | Cascade Infectious Diseases And Infusion Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639403330 PECOS PAC ID: 0143356360 Enrollment ID: O20100326000893 |
News Archive
Nerve cells that regulate everything from heart muscle to salivary glands send out projections known as axons to their targets. By way of these axonal processes, neurons control target function and receive molecular signals from targets that return to the cell body to support cell survival. Now, Johns Hopkins researchers have revealed a molecular mechanism that allows a signal from the target to return to the cell body and fulfill its neuron-sustaining mission.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that results from studies highlighting pre-clinical advances with its proprietary BiTE antibody technology were presented at the American Association for Cancer Research Annual Meeting in Washington, DC.
Senetek PLC, a Life Sciences company engaged in the research, development and commercialization of technologies that target the science of healthy aging, today announced that the Senetek Board of Directors has implemented a new Corporate Communication policy to insure that the highest standards of corporate governance are met and that full compliance with all public company regulations is in place.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jasmin Chaudhary, MD Po Box 317, Woodburn, OR 97071 Ph: (503) 989-0125 | Jasmin Chaudhary, MD 3025 Ryan Dr Se, Salem, OR 97301-5057 Ph: (503) 540-9999 |
News Archive
Nerve cells that regulate everything from heart muscle to salivary glands send out projections known as axons to their targets. By way of these axonal processes, neurons control target function and receive molecular signals from targets that return to the cell body to support cell survival. Now, Johns Hopkins researchers have revealed a molecular mechanism that allows a signal from the target to return to the cell body and fulfill its neuron-sustaining mission.
The Associated Press reports on "the national surge in elderly inmates whose medical expenses are straining cash-strapped states and have officials looking for solutions, including early release, some possibly to nursing homes. ... That burden is becoming greater as the American Civil Liberties Union estimates that elderly prisoners — the fastest growing segment of the prison population, largely because of tough sentencing laws — are three times more expensive to incarcerate than younger inmates.
Micromet, Inc., a biopharmaceutical company focused on the development and commercialization of next-generation antibodies for the treatment of cancer, today announced that results from studies highlighting pre-clinical advances with its proprietary BiTE antibody technology were presented at the American Association for Cancer Research Annual Meeting in Washington, DC.
Senetek PLC, a Life Sciences company engaged in the research, development and commercialization of technologies that target the science of healthy aging, today announced that the Senetek Board of Directors has implemented a new Corporate Communication policy to insure that the highest standards of corporate governance are met and that full compliance with all public company regulations is in place.
› Verified 5 days ago
Dr. Andrew P. Hope, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se, Suite 4000, Salem, OR 97301 Phone: 503-364-0189 Fax: 503-364-9288 | |
Brett W Mikeska, M D Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se Ste 5070, Salem, OR 97301 Phone: 503-561-8565 Fax: 503-561-8560 | |
Dr. Aneet Jyot Deo, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se Ste 5070, Salem, OR 97301 Phone: 503-561-8565 Fax: 503-561-8560 | |
Joseph J Thaler, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 5050 Skyline Village Loop S, Salem, OR 97306 Phone: 503-391-1110 Fax: 503-370-4237 | |
Dr. Krystyna Antonina Pekalska, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 2400 Lancaster Dr Ne, Salem, OR 97305 Phone: 503-361-5400 | |
Dr. Falguny I Bhavan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se, Ste 3010, Salem, OR 97301 Phone: 503-399-7520 Fax: 503-362-7344 | |
Dr. Douglas Michael Carney, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 960 Liberty St Se Ste 140, Salem, OR 97302 Phone: 503-540-0304 Fax: 503-540-0305 |